PTC Therapeutics (NasdaqGS:PTCT) Q2 2026 Earnings call July 30, 2026 04:30 PM ET Company Participants Ellen Cavaleri - Head of Investor Relations Matthew Klein - CEO Eric Pauwels - Chief Business Officer Pierre Gravier - CFO Conference Call Participants Kristen Kluska - Analyst Tazeen Ahmad - Analyst None - Analyst Eric Joseph - Analyst Ben Burnett - Analyst Brian Cheng - Analyst Judah Frommer - Analyst Joseph Thome - Analyst Faisal Khurshid - Analyst None - Analyst Luke Herrmann - Analyst Joe Schwartz - An ...